Glucocorticoid Receptor Antagonists for Ovarian Cancer — An Interview with Professor Nicoletta Colombo

Featuring an interview with Professor Nicoletta Colombo, including the following topics:

Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)

Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)

Definition of platinum ineligibility; importance of platinum-containing chemotherapy for patients with ovarian cancer (14:02)

Findings from a Phase II trial and the subsequent confirmatory Phase III ROSELLA study (20:25)

Phase III ROSELLA study: Subgroup analyses, patient-reported outcomes, insights into…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.